Position in ABBV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$261,857
+$51,875 QoQ
Shares Held
1,204
+31.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Vancity Investment Management Ltd holds $502,270 across 2 Drug Manufacturers - General names. ABBV ranks #1 (52.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
1,204 | $261,857 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
1,725 | $240,413 |
All Filings in ABBV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $261,857 | 1,204 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $209,982 | 919 | Shares | Sole | 2026-02-19 | |
| No filing history on record for this holder in this stock. | ||||||